Modelling haematopoietic malignancies in the mouse and therapeutical implications

Rosa Bernardi, Silvia Grisendi, Pier Paolo Pandolfi

Research output: Contribution to journalArticlepeer-review

Abstract

Modelling human disease in the mouse has become an essential activity in biomedical research in order to unravel molecular mechanisms underlying pathological conditions as well as to determine in vivo the consequences of aberrant gene function. The mouse is by far the most accessible mammalian system physiologically similar to humans. Furthermore, the development of novel techniques for manipulating the murine genome, which allow the in vivo modification of virtually any genomic region in a time and/or tissue specific manner, renders the mouse an ideal model system to study human pathological conditions. Modelling human diseases in mice has reached an even greater relevance in the field of haematological malignancies, due to the already advanced characterization of the molecular basis of many haematological disorders. In this review, we describe the most important technological developments that made it possible to reproduce in the mouse the genetic lesions that characterize human haematological malignancies, thus often generating faithful mouse models of the human condition. We provide specific examples of the advantages and limitations of the various genetic approaches utilized to model leukaemia and lymphoma in the mouse. Finally, we discuss the power of mouse modelling in developing and testing novel therapeutic modalities in pre-clinical studies.

Original languageEnglish
Pages (from-to)3445-3458
Number of pages14
JournalOncogene
Volume21
Issue number21 REV. ISS. 2
DOIs
Publication statusPublished - May 13 2002

Keywords

  • Animal models
  • Cre-loxP system
  • Knock-in
  • Leukaemias and lymphomas
  • Tetracycline-inducible system
  • Transgenic mice

ASJC Scopus subject areas

  • Cancer Research
  • Genetics
  • Molecular Biology

Fingerprint Dive into the research topics of 'Modelling haematopoietic malignancies in the mouse and therapeutical implications'. Together they form a unique fingerprint.

Cite this